As of Aug 14
| -0.86 / -0.89%|
The 21 analysts offering 12-month price forecasts for AbbVie Inc have a median target of 105.00, with a high estimate of 157.00 and a low estimate of 78.00. The median estimate represents a +9.47% increase from the last price of 95.92.
The current consensus among 23 polled investment analysts is to Hold stock in AbbVie Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.